GFM Network News


Investors pile into Bayer bond to pay settlement charges

Reading Time: < 1 minute Amsterdam | Reuters — Investors piled into a Bayer bond on Wednesday that will help pay for a long-negotiated settlement of U.S. lawsuits claiming its widely-used herbicide Roundup caused cancer. Demand for the four-tranche bond sale, whose proceeds will include the litigation payments, exceeded 17.5 billion euros, nearly three times the six billion euros (C$9.15 […] Read more

Bayer reporting progress in Roundup settlement talks

Reading Time: 2 minutes Frankfurt | Reuters — Bayer said on Monday it had made progress seeking a settlement over claims its glyphosate-based Roundup herbicide causes cancer, after Bloomberg reported the company reached a verbal agreement on about 50,000 to 85,000 cases. The drugs and pesticides group is keen to draw a line under the legal dispute, which it […] Read more


Roundup cancer trial postponed to continue settlement talks

Reading Time: < 1 minute Reuters — Bayer AG said on Friday it has reached an agreement with plaintiffs’ lawyers to postpone a Missouri jury trial over allegations its herbicide Roundup causes cancer, to provide room for negotiations to settle the litigation. “While Bayer is constructively engaged in the mediation process, there is no comprehensive agreement at this time. There […] Read more

Bayer seeks glyphosate litigation advice as Elliott reveals stake

Reading Time: 2 minutes Frankfurt | Reuters — Chemicals giant Bayer , under pressure from activist shareholders, said on Wednesday it has hired an external lawyer to advise its supervisory board and has set up a committee to help resolve a multi-billion dollar glyphosate litigation issue. Bayer has seen its share price tumble in the wake of its US$63 […] Read more


Investors call for reprieve for Bayer bosses after AGM rebuke

Reading Time: 2 minutes Frankfurt | Reuters — Three of Bayer’s largest German investors said the drugmaker’s embattled management needed to stay at the helm to avoid further upheaval, despite their unease over a share price slump in the wake of the US$63 billion Monsanto takeover. The backing for CEO Werner Baumann comes after an unprecedented rebuke at the […] Read more

Bayer shareholders vent ire over Monsanto-linked stock rout

Reading Time: 2 minutes Bonn | Reuters — Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker’s US$63 billion takeover of seed and chemical firm Monsanto. Several large investors said they will not support aspirin invesotr Bayer’s management in a key vote scheduled for the end of its […] Read more


Bayer reaps profit lift from Monsanto

Reading Time: 2 minutes Leverkusen, Germany | Reuters –– Bayer’s US$63 billion purchase of seed and chemical firm Monsanto made its mark on the German company’s fourth quarter earnings on Wednesday, lifting profit and boding well for the peak season of its enlarged agriculture business. However, mounting litigation risks related to Monsanto still cast a pall over an adjusted […] Read more

As the wind blows

Guide Legal: The legal implications of particle drift

Reading Time: 4 minutes In recent years, Canadian producers have significantly increased their use of genetically modified crops. At the same time, a growing number of farms are obtaining organic certification. The concurrent expansion of these two practices will almost inevitably lead to GM and organic fields being adjacent. What are the legal implications when GM products drift onto […] Read more